Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

Worldwide there are over 46 million people living with dementia, and this number is expected to double every 20 years reaching about 131 million by 2050. The cost to the community and government health systems, as well as the stress on families and carers is incalculable. Over three decades of resea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Alzheimers Dis
Main Authors: Martins, Ralph N., Villemagne, Victor, Sohrabi, Hamid R., Chatterjee, Pratishtha, Shah, Tejal M., Verdile, Giuseppe, Fraser, Paul, Taddei, Kevin, Gupta, Veer B., Rainey-Smith, Stephanie R., Hone, Eugene, Pedrini, Steve, Lim, Wei Ling, Martins, Ian, Frost, Shaun, Gupta, Sunil, O’Bryant, Sid, Rembach, Alan, Ames, David, Ellis, Kathryn, Fuller, Stephanie J., Brown, Belinda, Gardener, Samantha L., Fernando, Binosha, Bharadwaj, Prashant, Burnham, Samantha, Laws, Simon M., Barron, Anna M., Goozee, Kathryn, Wahjoepramono, Eka J., Asih, Prita R., Doecke, James D., Salvado, Olivier, Bush, Ashley I., Rowe, Christopher C., Gandy, Samuel E., Masters, Colin L.
Formato: Artigo
Idioma:Inglês
Publicado em: IOS Press 2018
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5870031/
https://ncbi.nlm.nih.gov/pubmed/29562546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-171145
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados